{
  "basic_data": [
    {
      "cell_line_alt_name": "UBC3 M1",
      "cell_type": "iPSC",
      "frozen": "True",
      "hpscreg_name": "CIAUi002-C"
    }
  ],
  "generator": [
    {
      "group": "Centenary Institute of Cancer Medicine and Cell Biology"
    }
  ],
  "contact": [
    {
      "first_name": "Christopher",
      "e_mail": "c.semsarian@centenary.org.au",
      "last_name": "Semsarian",
      "group": "Centenary Institute of Cancer Medicine and Cell Biology"
    }
  ],
  "publications": [
    {
      "last_author": "Christopher Semsarian",
      "year": "2023.0",
      "first_author": "Serena Li",
      "doi": "10.1016/j.scr.2023.103153",
      "journal": "Stem Cell Research",
      "title": "Generation of an induced pluripotent stem cell line from a patient with conduction disease and recurrent ventricular fibrillation with a sodium voltage-gated channel alpha subunit 5 (SCN5A) gene c.392 + 3A > G splice-site variant"
    }
  ],
  "donor": [
    {
      "sex": "Female",
      "age": "A30_34",
      "disease_description": "30 year old female with recurrent ventricular fibrillation, conduction disease, and non-ischemic cardiomyopathy",
      "disease_name": "Left bundle branch block"
    }
  ],
  "genomic_modifications": [
    {
      "description": "No genetic modification; heterozygous SCN5A c.392 + 3A > G splice-site variant",
      "loci_name": "SCN5A",
      "genotype": "Heterozygous SCN5A c.392 + 3A > G"
    }
  ],
  "differentiation_results": [
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EN",
      "marker_list": "SOX17; CXCR4",
      "method_used": "Immunostaining"
    },
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "ME",
      "marker_list": "NKX2.5; TNNT2",
      "method_used": "Immunostaining"
    },
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EC",
      "marker_list": "PAX6; NESTIN",
      "method_used": "Immunostaining"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "18",
      "karyotype": "46,XX",
      "summary": "Normal female karyotype with no aneuploidies confirmed at passage 18.",
      "karyotype_method": "MKSNP"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_origin_term": "blood",
      "derivation_year": "2021",
      "non_int_vector_name": "[kit] Episomal iPSC Reprogramming Plasmids",
      "i_source_cell_type_term": "Peripheral Blood Mononuclear Cells (PBMCs)",
      "non_int_vector": "Episomal"
    }
  ],
  "ethics": [
    {
      "institutional_HREC": "Sydney Local Health District Ethics Review Committee",
      "ethics_number": "X19-0108 and 2019/ETH00461"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "passage_method": "EN"
    }
  ]
}